Palvella Therapeutics

PVLA

141.7702.72% ( +3.760 )

Closed: Jul 27, 16:00:00 (EDT)

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Palvella Therapeutics(PVLA) predict that the EBIT is -14.86 M (-88.73%), Miss estimate;the EPS is -1.2 (-62.16%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

Revenue

TBA--

0.00B--

----

EBITMiss expectations

-0.01B88.73%

-0.01B61.80%

-0.00B26.93%

EPSMiss expectations

-1.262.16%

-0.940827.14%

-0.259235.02%

ActualEstimateUnit: USD

ActualEstimateUnit: USD

ActualEstimateUnit: USD

ActualEstimateUnit: USD